 |
 |
Search
- Page Path
-
- HOME
- Search
- Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5–24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study
- Lu Wang, Ying-Jie Dai, Yu Cui, Hong Zhang, Chang-Hao Jiang, Ying-Jie Duan, Yong Zhao, Ye-Fang Feng, Shi-Mei Geng, Zai-Hui Zhang, Jiang Lu, Ping Zhang, Li-Wei Zhao, Hang Zhao, Yu-Tong Ma, Cheng-Guang Song, Yi Zhang, Hui-Sheng Chen
- J Stroke. 2023;25(3):371-377. Published online August 24, 2023
-
Full text 
PubReader 
ePub 
PDF
- Replacing Alteplase with Tenecteplase: Is the Time Ripe?
- Nishita Singh, Bijoy K. Menon, Adam A. Dmytriw, Robert W. Regenhardt, Joshua A. Hirsch, Aravind Ganesh
- J Stroke. 2023;25(1):72-80. Published online January 31, 2023
-
Full text PubReader ePub PDF
Supplementary Materials
- Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
- Mahesh Kate, Robert Wannamaker, Harsha Kamble, Parnian Riaz, Laura C. Gioia, Brian Buck, Thomas Jeerakathil, Penelope Smyth, Ashfaq Shuaib, Derek Emery, Kenneth Butcher
- J Stroke. 2018;20(1):122-130. Published online January 31, 2018
-
Full text PubReader ePub PDF
| 1 | |
-
Editorial Office
Department of Neurology, Asan Medical Center,Ulsan University College of Medicine
88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea
Submission, status and progress, etc ⟫ E-mail: editor@j-stroke.org
Website and system ⟫ E-mail: journal@m2community.co.kr
Publishing company ⟫ E-mail: ka72sus@smileml.com
Copyright © 2024 by Korean Stroke Society.